31 August 2023 (Thursday) - Oncology Central Update

 

The nice people at “Oncology Central” sent their update today. Perhaps not directly relevant to what I do, but useful background reading.

I found the “internet etiquette” fascinating… do healthcare professionals *really* need to be told something quite so obvious?

Editor's pick

US FDA drug approvals in oncology: the latest news   Across August there have been several noteworthy approvals from the FDA, including one for Pfizer (NY, USA) and two for Janssen (Belgium). Discover the latest approvals in the States by checking out our roundup article.

Latest articles

Netiquette for social media engagement for oncology professionals   This Perspective article, published in Future Oncology, describes how to create a social media identity and outlines best practices for engaging both in patient spaces and professional communities.

Does lowering alcohol intake reduce the risk of cancer?   Are you aware of the potential link between alcohol consumption and cancer? 🍻 Dive into this insightful article and discover facts that could change your perspective.

Precision oncology: a clinical and patient perspective   Characterization of cancer tumors using genomic biomarkers has prompted a shift toward personalized treatment strategies for cancer patients. This article from Future Oncology reviews the status of precision oncology medicine and emphasizes its impact on patients.

Topics: Cancer biology and pathology | Clinical trials | Drug approvals | Drug development | Diagnostics | Epidemiology | Genetics and genomics | Immuno- oncology | Industry and business | Patient perspective | Personalized medicine | Preclinical research and trials | Prevention and screening | Targeted therapies |